Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma

Gastroenterology

Volumn 145, Issue 5, 2013, Pages 1121-1132

  Ene Obong, Abasi ^a   Clear, Andrew J ^a   Watt, Jennifer ^a,b   Wang, Jun ^a   Fatah, Rewas ^a   Riches, John C ^a   Marshall, John F ^a   Chin Aleong, Joanne ^b   Chelala, Claude ^a   Gribben, John G ^a   Ramsay, Alan G ^a   Kocher, Hemant M ^a,b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

Antitumor Immunity; Immune Regulation; Mouse Model; Pancreatic Cancer

Indexed keywords

RETINOIC ACID; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CELL ADHESION; CELL TYPE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; IMMUNOCOMPETENT CELL; LEUKOCYTE MIGRATION; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREATIC STELLATE CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA INTERFERENCE; TISSUE MICROARRAY;

EID: 84886780808     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2013.07.025     Document Type: Article

References (38)

1. P.A. Perez-Mancera, C. Guerra, and M. Barbacid What we have learned about pancreatic cancer from mouse models Gastroenterology 142 2012 1079 1092
2. R.D. Schreiber, L.J. Old, and M.J. Smyth Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion Science 331 2011 1565 1570
3. M.D. Vesely, M.H. Kershaw, and R.D. Schreiber Natural innate and adaptive immunity to cancer Annu Rev Immunol 29 2011 235 271
4. N.P. Restifo, M.E. Dudley, and S.A. Rosenberg Adoptive immunotherapy for cancer: harnessing the T cell response Nat Rev Immunol 12 2012 269 281
5. H. Matsushita, M.D. Vesely, and D.C. Koboldt Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting Nature 482 2011 400 404
6. L. Zhang, J.R. Conejo-Garcia, and D. Katsaros Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer N Engl J Med 348 2003 203 213
7. J. Galon, A. Costes, and F. Sanchez-Cabo Type, density, and location of immune cells within human colorectal tumors predict clinical outcome Science 313 2006 1960 1964
8. C.E. Clark, S.R. Hingorani, and R. Mick Dynamics of the immune reaction to pancreatic cancer from inception to invasion Cancer Res 67 2007 9518 9527
9. D. Nummer, E. Suri-Payer, and H. Schmitz-Winnenthal Role of tumor endothelium in CD4+ CD25+ regulatory T cell infiltration of human pancreatic carcinoma J Natl Cancer Inst 99 2007 1188 1199
10. A. Neesse, P. Michl, and K.K. Frese Stromal biology and therapy in pancreatic cancer Gut 60 2011 861 868
11. F.E. Froeling, C. Feig, and C. Chelala Retinoic acid-induced pancreatic stellate cell quiescence reduces paracrine wnt-beta-catenin signaling to slow tumor progression Gastroenterology 141 2011 1486 1497
12. C.A. Iacobuzio-Donahue, B. Ryu, and R.H. Hruban Exploring the host desmoplastic response to pancreatic carcinoma: gene expression of stromal and neoplastic cells at the site of primary invasion Am J Pathol 160 2002 91 99
13. F. Ricci, S.E. Kern, and R.H. Hruban Stromal responses to carcinomas of the pancreas: juxtatumoral gene expression conforms to the infiltrating pattern and not the biologic subtype Cancer Biol Ther 4 2005 302 307
14. F.E. Froeling, T.A. Mirza, and R.M. Feakins Organotypic culture model of pancreatic cancer demonstrates that stromal cells modulate E-cadherin, beta-catenin, and Ezrin expression in tumor cells Am J Pathol 175 2009 636 648
15. A.M. Lee, A.J. Clear, and M. Calaminici Number of CD4+ cells and location of forkhead box protein P3-positive cells in diagnostic follicular lymphoma tissue microarrays correlates with outcome J Clin Oncol 24 2006 5052 5059
16. Yale University. X-Tile, 2004.
17. R.L. Camp, M. Dolled-Filhart, and D.L. Rimm X-Tile Clin Cancer Res 10 2004 7252 7259
18. D.G. Altman, B. Lausen, and W. Sauerbrei Dangers of using "optimal" cutpoints in the evaluation of prognostic factors J Natl Cancer Inst 86 1994 829 835
19. W. Huang da, B.T. Sherman, and R.A. Lempicki Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources Nat Protoc 4 2009 44 57
20. R. Kadaba, H. Birke, and J. Wang Imbalance of desmoplastic stromal cell numbers drives aggressive cancer processes J Pathol 230 2013 107 117
21. V.H. Coupland, H.M. Kocher, and D.P. Berry Incidence and survival for hepatic, pancreatic and biliary cancers in England between 1998 and 2007 Cancer Epidemiol 36 2012 e207 e214
22. Y. Pylayeva-Gupta, E. Lee Kyoung, and H. Hajdu Cristina Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia Cancer Cell 21 2012 836 847
23. J. Bayne Lauren, L. Beatty Gregory, and N. Jhala Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer Cancer Cell 21 2012 822 835
24. K.P. Olive, M.A. Jacobetz, and C.J. Davidson Inhibition of hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer Science 324 2009 1457 1461
25. X. Wu, Y. Zou, and X. He Tumor-infiltrating mast cells in colorectal cancer as a poor prognostic factor Int J Surg Pathol 21 2013 111 120
26. M.V. Apte, J.S. Wilson, and A. Lugea A starring role for stellate cells in the pancreatic cancer microenvironment Gastroenterology 144 2013 1210 1219
27. C.C. Bleul, R.C. Fuhlbrigge, and J.M. Casasnovas A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1) J Exp Med 184 1996 1101 1109
28. B. Lee, M. Sharron, and L.J. Montaner Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages Proc Natl Acad Sci U S A 96 1999 5215 5220
29. J.C. Riches, J.K. Davies, and F. McClanahan T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production Blood 121 2013 1612 1621
30. C.A. Iacobuzio-Donahue, A. Maitra, and G.L. Shen-Ong Discovery of novel tumor markers of pancreatic cancer using global gene expression technology Am J Pathol 160 2002 1239 1249
31. I. Poschke, and R. Kiessling On the armament and appearances of human myeloid-derived suppressor cells Clin Immunol 144 2012 250 268
32. T.A. Mace, Z. Ameen, and A. Collins Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a STAT3-dependent manner Cancer Res 73 2013 3007 3018
33. M. Kraman, P.J. Bambrough, and J.N. Arnold Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha Science 330 2010 827 830
34. G.L. Beatty, E.G. Chiorean, and M.P. Fishman CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans Science 331 2011 1612 1616
35. D. Lindau, P. Gielen, and M. Kroesen The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells Immunology 138 2013 105 115
36. D.J. Campbell, and M.A. Koch Phenotypical and functional specialization of FOXP3+ regulatory T cells Nat Rev Immunol 11 2011 119 130
37. A.P. Singh, S. Arora, and A. Bhardwaj CXCL12/CXCR4 protein signaling axis induces sonic hedgehog expression in pancreatic cancer cells via extracellular regulated kinase- and Akt kinase-mediated activation of nuclear factor κB: implications for bidirectional tumor-stromal interactions J Biol Chem 287 2012 39115 39124
38. E. Lonardo, J. Frias-Aldeguer, and P.C. Hermann Pancreatic stellate cells form a niche for cancer stem cells and promote their self-renewal and invasiveness Cell Cycle 11 2012 1282 1290